Circulating irisin is associated with osteoporotic fractures in postmenopausal women with low bone mass but is not affected by either teriparatide or denosumab treatment for 3 months. Επικοινωνία Submitted by Στέργιος Πολύζος on Δευ, 11/18/2019 - 10:45
